AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8040603
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g fish oil daily for 3 or 6 months (containing 18% eicosapentaenoic acid and 12% docosahexaenoic acid)
Trial: 8040603
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g fish oil daily for 3 or 6 months
Trial: 3055324
Drug: Tenoretic 100
RxNorm normalized name: Tenoretic 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoretic 100 (atenolol 100 mg; chlorthalidone 25 mg)
Trial: 3055324
Drug: Tenoretic 50
RxNorm normalized name: Tenoretic 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoretic 50 (atenolol 50 mg; chlorthalidone 25 mg)
Trial: 31268555
Drug: Staccato alprazolam
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Staccato alprazolam 1.0 mg
Trial: 31268555
Drug: Staccato alprazolam
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Staccato alprazolam 2.0 mg
Trial: 29792052
Drug: CBT4CBT with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBT4CBT with brief weekly monitoring
Trial: 24099551
Drug: Suboxone tablets
DrugBank: Naloxone (DB01183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suboxone tablets (8/2mg)
Trial: 24099551
Drug: Suboxone tablets
DrugBank: Naloxone (DB01183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suboxone tablets and films
Trial: 21377898
Drug: Intradermal vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal vaccine (6 μg hemagglutinin per strain)
Trial: 21377898
Drug: Intramuscular vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vaccine (15 μg hemagglutinin per strain)
Trial: 9314448
Drug: Intramuscular vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vaccine
Trial: 9695720
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg itraconazole once daily for 4 days
Trial: 11372588
Drug: Matched placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched placebo once daily for 4 days
Trial: 9589673
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human GH treatment
Trial: 27475670
Drug: Moderately hypofractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately hypofractionated radiation therapy (MHRT) - 62 Gy in 20 fractions over 5 weeks
Trial: 27475670
Drug: Conventional fractionated
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fractionated radiation therapy (CFRT) - 80 Gy in 40 fractions over 8 weeks
Trial: 25431225
Drug: Qishenyiqi Dripping
RxNorm normalized name: DRIP COLLECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qishenyiqi Dripping Pills
Trial: 11818981
Drug: Paico juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paico juice (1 ml/Kg for <10 Kg, 2 ml/Kg for >10 Kg, one dose before breakfast for three consecutive days)
Trial: 11818981
Drug: Albendazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (400 mg for >5 years, 200 mg for <5 years, single dose)
Trial: 10194990
Drug: Fentanyl infusion
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl infusion (1.1 micrograms/kg/h for 75 hours)
Trial: 7917782
Drug: Proximal site
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Proximal site perfusion of paracetamol
Trial: 7917782
Drug: Distal site
RxNorm normalized name: SOLO SITE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distal site perfusion of paracetamol
Trial: 31547675
Drug: Rapeseed meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapeseed meal (RSM) and maize gluten (MG)
Trial: 29211951
Drug: 2.6% edathamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.6% edathamil gel (Livionex® Dental Gel)
Trial: 25266794
Drug: 0.5 L
RxNorm normalized name: AIR 20.5 L in 100 L RESPIRATORY (INHALATION) GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 L hydroxyethyl starch 6% 130/0.42 (Group T)
Trial: 25266794
Drug: 1 L
RxNorm normalized name: BLUE 1 LAKE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 L Ringer's lactate (Group R/L)
Trial: 22161540
Drug: ColoPlus® (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ColoPlus® (50 g twice a day for 4 weeks)
Trial: 22161540
Drug: Standard anti-diarrhea
RxNorm normalized name: loperamide hydrochloride Oral Solution [Anti-Diarrhea]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard anti-diarrhea treatment alone
Trial: 17115349
Drug: Insulin aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin aspart (IAsp) + human isophane insulin (NPH)
Trial: 11530155
Drug: Culturally-based health
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culturally-based health promotion programme introduced in 1981, details on dosage and duration not applicable.
Trial: 7756706
Drug: Gentamicin 2
RxNorm normalized name: gentamicin 2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 2 mg/kg
Trial: 9145878
Drug: Gentamicin 7
RxNorm normalized name: gentamicin 70 mg/50 mL-0.9% intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 7 mg/kg
Trial: 8198053
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (900 mg d-alpha-tocopherol/d)
Trial: 30194502
Drug: Combination HIV-prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination HIV-prevention and microfinance intervention including HIV-risk reduction, financial-literacy training, vocational training, and a matched-savings program.
Trial: 27838190
Drug: Hormonal therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal therapy with vigabatrin
Trial: 30236380
Drug: Initial control
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial control of spasms between days 14 and 42 of treatment
Trial: 30236380
Drug: Increasing lead-time
RxNorm normalized name: lead
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increasing lead-time to treatment
Trial: 27772740
Drug: Prolonged-release fampridine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release fampridine (10mg, twice daily)
Trial: 23306418
Drug: CoQ10 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoQ10 (200 mg daily)
Trial: 20881069
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (10 mg ZnO/d for 5 d/wk)
Trial: 20881069
Drug: Placebo (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (10 mg glucose)
Trial: 18594845
Drug: 5-FU/oxaliplatin-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU/oxaliplatin-based chemotherapy (FUFOX vs. CAPOX)
Trial: 12846707
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 0.1 mg.kg‐1 postinduction (EP group, n = 25)
Trial: 12846707
Drug: Morphine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine infusion at 0.02 mg.kg‐1.h‐1 following 0.05 mg.kg‐1 bolus (INF group, n = 25)
Trial: 6088819
Drug: Acyclovir 200
RxNorm normalized name: acyclovir 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 200 mg capsules orally five times daily for ten days
Trial: 6088819
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules orally five times daily for ten days
Trial: 6088819
Drug: Acyclovir 200
RxNorm normalized name: acyclovir 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 200 mg capsules
Trial: 23147696
Drug: JTT-751 (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JTT-751 (1.5 g/day)
Trial: 23147696
Drug: JTT-751 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JTT-751 (3 g/day)
Trial: 23147696
Drug: JTT-751 (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JTT-751 (6 g/day)
Trial: 17526169
Drug: Liuwei Dihuang
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liuwei Dihuang Soft Capsule (LDSC) plus Ginkgo Leaf Tablet (GLT)
Trial: 9437777
Drug: Single-dose azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Single-dose azithromycin (5.1%, 5/98 positive for C. trachomatis)
Trial: 9437777
Drug: Multidose therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidose therapy compliance (94.5% among 73 women)
Trial: 31318832
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate administration
Trial: 26075538
Drug: Testosterone replacement
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone replacement therapy (TRT) - 250 mg of testosterone enanthate as an intramuscular injection every 4 weeks for 6 months
Trial: 1539754
Drug: Ivermectin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin (150 micrograms/kg body weight) given once every three months for four, eight, or eleven doses
Trial: 2951792
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of fenoterol and ipratropium bromide
Trial: 28676038
Drug: Oral sildenafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sildenafil
Trial: 31095126
Drug: Normobaric interval
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normobaric interval hypoxic therapy and enteral oxygen therapy
Trial: 22939108
Drug: Methylprednisolone 20
RxNorm normalized name: methylprednisolone 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 20 mg/kg
Trial: 18602726
Drug: TIV from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIV from multi‐dose vials with thimerosal
Trial: 15354456
Drug: 0.42% fluoride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.42% fluoride gel
Trial: 15354458
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no fluoride gel)
Trial: 8497343
Drug: Estradiol (E2)
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol (E2) sequentially combined with 10 mg of medroxyprogesterone acetate
Trial: 3305088
Drug: Triamterene (potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triamterene (potassium blocking agent)
Trial: 29338855
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg twice daily vaginal Endometrin
Trial: 29338855
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg daily intramuscular P only
Trial: 29338855
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg twice daily Endometrin plus 50 mg intramuscular P every 3rd day
Trial: 26908758
Drug: Intravaginal metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal metronidazole (750 mg) plus miconazole (200 mg) for 5 consecutive nights each month for 12 months
Trial: 24751822
Drug: Ferric carboxymaltose
RxNorm normalized name: Ferric Carboxymaltose
DrugBank: Ferric carboxymaltose (DB08917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric carboxymaltose (FCM) 1000 mg iron
Trial: 23412930
Drug: Spironolactone 25mg
RxNorm normalized name: SPIRONOLACTONE 25MG TAB
DrugBank: Spironolactone (DB00421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spironolactone 25mg daily (n = 58)
Trial: 16834833
Drug: Chlorpheniramine 6
RxNorm normalized name: carbetapentane-chlorpheniramine 60 mg-5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine 6 mg
Trial: 3446535
Drug: No ALT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ALT treatment following PI or LI
Trial: 29645341
Drug: Sitagliptin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin (100 mg once daily)
Trial: 20346182
Drug: 0.03 IU/min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03 IU/min vasopressin infusion
Trial: 20214761
Drug: Artesunate-amodiaquine (Camoquin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artesunate-amodiaquine (Camoquin plus) dosed at 300 and 600 mg of amodiaquine per tablet
Trial: 15585538
Drug: Cognitive behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behaviour therapy (10 sessions over five months)
Trial: 12391340
Drug: Low-flow ventriculoperitoneal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-flow ventriculoperitoneal shunt treatment
Trial: 10518856
Drug: Dental floss
RxNorm normalized name: dental floss
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental floss containing 0.25 mg tetrasodium pyrophosphate per cm
Trial: 8077370
Drug: Percutaneous estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Percutaneous estradiol administration (100 micrograms)
Trial: 1228009
Drug: Betamethasone 17-valerate
RxNorm normalized name: Cortisol 17-valerate
DrugBank: Hydrocortisone valerate (DB14544)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone 17-valerate in a cream base containing DMSO
Trial: 11327066
Drug: One-stage full-mouth
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-stage full-mouth (OSFM) disinfection treatment
Trial: 29992831
Drug: MPFF 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPFF 1000 mg once daily
Trial: 29992831
Drug: MPFF 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPFF 500 mg twice daily
Trial: 27129012
Drug: Olokizumab administered
RxNorm normalized name: olokizumab
DrugBank: Olokizumab (DB13127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olokizumab administered intravenously (iv) or subcutaneously (sc)
Trial: 22744665
Drug: Fipamezole 90
RxNorm normalized name: Fipamezole
DrugBank: Fipamezole (DB06585)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fipamezole 90 mg TID
Trial: 19639377
Drug: Purified black
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified black tea theaflavins (TFs) providing 77.5 mg
Trial: 19639377
Drug: Purified black
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified black tea theaflavins/catechins (TFs/catechins) providing 75.0 mg TFs plus 150.0 mg catechins and 195.0 mg of other polyphenols
Trial: 17923296
Drug: Home therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home therapy exercises after carpal tunnel release
Trial: 17923296
Drug: Home therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home therapy exercises plus therapist-directed program for 2 weeks
Trial: 19330802
Drug: Mirtazapine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (30 mg/day)
Trial: 12196367
Drug: Usual information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual information treatment options
Trial: 10381769
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg MDMA
Trial: 22269534
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg MDMA
Trial: 10622275
Drug: Alcohol (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.8 mg/kg)
Trial: 7860949
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg sodium PHT plus 1 mg folic acid per day
Trial: 7860949
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg sodium PHT per day
Trial: 1949301
Drug: Recombinant tissue
RxNorm normalized name: Tissue plasminogen activator, recombinant
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Recombinant tissue plasminogen activator (tPA) (100 mg over 3 hours)
Trial: 1949301
Drug: Subcutaneous heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous heparin (12,500 U twice daily)
Trial: 17475736
Drug: Interpersonal psychotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal psychotherapy plus pharmacotherapy
Trial: 17475736
Drug: Clinical management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical management (medication plus intensive clinical management)
Trial: 7645553
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of antibody concentrations post-vaccination
Trial: 334604
Drug: Ketoprofen (Orudis)
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoprofen (Orudis) 100 mg suppository nightly for ten days
Trial: 334604
Drug: Indomethacin suppository
RxNorm normalized name: indomethacin Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin suppository nightly for ten days
Trial: 21362108
Drug: nabiximols (Sativex)
RxNorm normalized name: Castanea sative leaf extract
DrugBank: Nabiximols (DB14011)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nabiximols (Sativex) as add-on therapy
Trial: 18164919
Drug: Tramadol ER
RxNorm normalized name: tramadol Extended Release Oral Capsule
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol ER 100 mg, 200 mg, and 300 mg
Trial: 18164919
Drug: Tramadol ER
RxNorm normalized name: tramadol Extended Release Oral Capsule
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol ER 200 mg and 300 mg
Trial: 15181043
Drug: Ringer solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer solution (control)
Trial: 11773991
Drug: Spirapril 3
RxNorm normalized name: spirapril 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 3 mg once a day
Trial: 11773991
Drug: Spirapril 6
RxNorm normalized name: spirapril 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 6 mg once a day
Trial: 101317
Drug: Aqueous pollen
RxNorm normalized name: ethylcellulose aqueous dispersion type A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous pollen extract (SDV), 18 doses
Trial: 101317
Drug: Glutaraldehyde-treated pollen-tyrosine
RxNorm normalized name: Tyrosine
DrugBank: Tyrosine (DB00135)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutaraldehyde-treated pollen-tyrosine adsorbate (Pollinex), 3 doses
Trial: 31682941
Drug: Digital DPP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital DPP (small group support, personalized health coaching, digital tracking tools, weekly behavior change curriculum)
Trial: 24778436
Drug: Baby Triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baby Triple P (8 sessions) + Treatment as Usual (TAU)
Trial: 17908750
Drug: Increase in
RxNorm normalized name: Incruse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increase in breast milk ingestion (10 mL/kg per day)
Trial: 16225606
Drug: Excimer laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Excimer laser treatment (twice weekly)
Trial: 16225606
Drug: Pulsed Dye
RxNorm normalized name: amaranth dye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed Dye Laser (PDL) treatment (every 4 weeks, pretreated with salicylic acid)
Trial: 9059669
Drug: Topical steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroid treatment for 4 weeks
Trial: 3567121
Drug: Oxytocin titration
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin titration to achieve a preset frequency of 6-7 uterine contractions every 15 min
Trial: 3567121
Drug: Oxytocin titration
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin titration to achieve uterine activity equivalent to the 75th centile for spontaneous labour
Trial: 21406450
Drug: Autologous blood
RxNorm normalized name: Banked autologous blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous blood injection (ABI)
Trial: 19136752
Drug: Caudal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal block with bupivacaine and sufentanil combination
Trial: 2553235
Drug: Weekly doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly doxorubicin (ADR)
Trial: 960908
Drug: +)-cyanidanol-3 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: +)-cyanidanol-3 (2 g daily, administered orally)
Trial: 960908
Drug: +)-cyanidanol-3 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: +)-cyanidanol-3 (1 g daily)
Trial: 23945134
Drug: Tocilizumab (TCZ)
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab (TCZ) 4 or 8 mg/kg every four weeks
Trial: 19965519
Drug: Interferon-beta 1a
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-beta 1a (intramuscular)